May 30, 2026 to June 3, 2026
Henry Cheng International Conference Centre
Asia/Hong_Kong timezone

l-Menthol enhances intestinal barrier function in a rat model of irritable bowel syndrome through intestine-luminal exposure

Not scheduled
20m
Henry Cheng International Conference Centre

Henry Cheng International Conference Centre

Others

Speaker

Dr Chen Cheng (Shanghai Institute of Materia Medica, Chinese Academy of Sciences)

Description

Background: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder in which impaired intestinal barrier integrity contributes to immune activation, visceral hypersensitivity, and disrupted gut–brain communication. Peppermint oil, rich in l-menthol, is clinically effective for IBS symptom relief; however, its role in improving intestinal barrier function remains unclear. In addition, rapid absorption raises questions about whether sufficient intestinal luminal exposure is maintained for barrier protection.
Methods: An IBS-D rat model was established using water-avoidance stress combined with chronic unpredictable stress. The effects of oral l-menthol were evaluated by measuring visceral sensitivity and intestinal barrier function. Pharmacokinetic analyses quantified luminal and systemic exposure to l-menthol and its metabolites in rats. In humans, plasma l-menthol metabolites were measured after oral administration of an l-menthol–containing herbal formulation (Lianhua Qingwen). In vitro studies investigated l-menthol metabolism and transport mechanisms.
Results: Oral l-menthol (28 or 56 mg/kg, twice daily for 7 days) significantly alleviated visceral hypersensitivity and improved bowel function in IBS-D rats. It restored barrier integrity, as indicated by reduced FITC-dextran permeability and decreased plasma diamine oxidase and D-lactate levels. Tight junction proteins (ZO-1, claudin-1, occludin) were upregulated, while pro-inflammatory cytokines (IL-6, IL-1β, TNF-α) were suppressed. L-menthol also modulated neurotransmitters (5-HT, SP, VIP) and reshaped gut microbiota, increasing Bifidobacterium and Lactobacillus. Pharmacokinetic data showed extensive first-pass glucuronidation followed by microbial deconjugation, sustaining high luminal exposure.
Conclusion: L-menthol improves intestinal barrier function, reduces inflammation, and modulates gut microbiota, thereby alleviating IBS-D symptoms. Sustained luminal exposure via metabolic recycling supports its therapeutic potential.

Author

Dr Chen Cheng (Shanghai Institute of Materia Medica, Chinese Academy of Sciences)

Co-authors

Ms Tongtong Liu (Shanghai Institute of Materia Medica, Chinese Academy of Sciences) Dr Muzi Li (Shanghai Institute of Materia Medica, Chinese Academy of Sciences) Prof. Chuan Li (Shanghai Institute of Materia Medica, Chinese Academy of Sciences)

Presentation materials

There are no materials yet.